BMC Cancer

Table 3 Multiple regression analysis of the QLQ-C30 and CoQoLo scores

From: Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional study

		QLQ-C30; Global health status			CoQoLo; Core domain total
		Coefficient	95% CI	p-value	Coefficient	95% CI	p-value
Age at survey
	−59	0			0
	60–69	−3.08	−14.48, 8.33	0.594	2.44	−2.69, 7.56	0.348
	70–79	−4.55	−16.52, 7.43	0.454	2.25	−3.13, 7.63	0.409
	80-	1.10	−14.83, 17.03	0.891	4.97	− 2.19, 12.13	0.172
Sex
	Male	0			0
	Female	10.89	1.30, 20.48	0.026	4.03	−0.28, 8.34	0.067
Years from diagnosis
	< 2	0			0
	≥ 2	−10.36	−18.53, −2.19	0.011	−4.73	−8.40, − 1.06	0.012
Treatment
	Surgery
	(−)	0			0
	(+)	4.99	−3.30, 13.27	0.235	1.10	−2.62, 4.82	0.558
Chemotherapy
	(−)	0			0
	(+)	−5.75	−15.50, 4.00	0.245	0.65	−3.73, 5.04	0.768
Radiation
	(−)	0			0
	(+)	1.25	−2.56, 5.06	0.65	1.25	−2.56, 5.06	0.65
Palliative care
	(−)	0			0
	(+)	−2.63	−5.93, 0.66	0.116	−2.63	−5.92, 0.66	0.116
Performance Status
	0	0			0
	1	−16.55	−27.26, −5.84	0.003	−3.54	−8.36, 1.26	0.147
	2	−34.49	−47.69, −21.28	0.000	−7.64	−13.57, − 1.71	0.012
	3	−40.97	−53.78, −28.15	0.000	−11.42	−17.18, − 5.67	0.000
	4	−73.01	− 102.99, − 43.02	0.000	−24.09	− 37.56, −10.62	0.001
Compensation
	Not approved	0			0
	Approved	5.86	−2.98, 14.70	0.192	1.75	−2.22, 5.72	0.385
Patient advocacy group
	Non-member	0			0
	Member	0.97	−7.47, 9.41	0.821	0.15	−3.64, 3.95	0.936

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com